Evidence map›Paper›PMID 31282132›Full record

ArticleStem cells translational medicine2019

Science and Social Media.

Alan Regenberg

Abstract read
In one paragraph

Article in Stem cells translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Content quality and reliability of mental health videos for cancer patients on social media platforms: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Impact of the COVID-19 Pandemic on the Dental Preferences of Patients in the Private Sector.International journal of environmental research and public health · 2022
    Article
  6. User Experience and Sustainability of 3D Printing in Dentistry.International journal of environmental research and public health · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alan RegenbergJohns Hopkins Berman Institute of Bioethics, Baltimore, Maryland, USA.ORCID 0000-0003-0604-9596

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

He Jiankui et al. conducted an experiment that resulted in the birth of the first human babies with germline gene editing. Initial and predominant communications of their work occurred via social media and outside of the norms for reviewing, approving, and engaging around work in science. This case provides an opportunity to reflect on the evolving and increasing presence of social media in science, its strengths, weaknesses, and the potential to develop applications that improve how we review, approve, and engage around the work of science. Social media use in science presents significant challenges. The potential benefits of addressing these challenges and developing new social media tools include greater transparency, access, and engagement-and could nurture the public's trust. Stem Cells Translational Medicine 2019;8:1226&1229.

Indexed as

CommunicationMarketingSocial NetworkingGene EditingHumansPublic OpinionScienceSocial Media

Identifiers

PMID31282132
PMCPMC6877767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.